Palmetto GBA, a Medicare administrative contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Oncotype DXGenomic Prostate Score issued a draft LCD that recommends Medicare coverage for use of the test in qualified patients with favorable intermediate-risk prostate cancer.
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
